Please Wait.....
Report
Gene Delivery Technologies Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
Market Report I 2023-07-28 I 300 Pages I Infinium Global Research and Consulting Solutions
The report on the global brewing ingredients market provides qualitative and quantitative analysis for the period from 2021-2030. The revenue generated by the market was USD 3475.26 Million in 2022 and is expected to reach USD 10812.92 Million in 2030, with a CAGR of 15.75% till 2030 during the projected period. The study on brewing ingredients market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
Gene delivery technologies are essential for various applications in research, medicine, and biotechnology, such as gene therapy, genetic engineering, and studying gene function. Gene delivery technology can further be classified into viral-based, non-viral-based, and combined hybrid systems. Viral-mediated gene delivery systems utilize modified viruses that are rendered replication-deficient but still capable of delivering DNA for gene expression. Commonly used viral vectors include retroviruses, lentiviruses, adenoviruses, and Adeno-associated Viruses (AAV). Non-viral gene delivery systems were created as a substitute for viral-based systems, offering an alternative approach to delivering genes into target cells. Furthermore, rising genetic and inherited diseases among the population across the globe are supporting the growth of the market during the forecasted period.
Viral gene delivery systems are anticipated to maintain their dominant position in the delivery systems segment of the gene delivery technologies market. These systems have undergone extensive research and development for gene therapy applications, establishing themselves as the preferred choice for delivering genes into target cells. By utilizing viral vectors like adenoviruses, lentiviruses, and Adeno-associated Viruses (AAVs), viral gene delivery systems efficiently transport therapeutic genes into cells. These vectors are carefully modified to ensure the safe and effective delivery of the desired genetic material. The viral-based approach offers several advantages, including high transduction efficiency, the ability to target specific cell types, and the potential for long-term gene expression. These qualities have contributed to successful clinical applications of viral gene delivery in various diseases.
North America has been a significant presence of the key players in the gene delivery technologies market, particularly due to the extensive number of clinical trials conducted in the region. The United States, in particular, has been at the forefront of gene therapy research and development. Gene therapies hold great promise for offering potential treatments for various diseases caused by genetic mutations or degeneration, including cancer, HIV/AIDS, and genetic disorders. The United States has seen a significant number of clinical trials focused on evaluating the safety and efficacy of gene therapies for these conditions. Furthermore, many companies in the field of gene therapy have prioritized the supply and commercialization of gene therapies and technologies, with a particular emphasis on the major organizations and headquarters located in the United States. This has contributed to North America's leadership in the Gene Delivery Technologies market.
Report Findings
1) Drivers
- Increasing genetic and inherited diseases among the population drive the growth of the market.
- The growing demand for targeted therapeutics propels the growth of the market.
2) Restraints
- The adverse effect related to gene therapy hampers the growth of the market.
3) Opportunities
- The rising investment in Research and Development (R&D) is a crucial factor that presents a significant opportunity for the market.
Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global gene delivery technologies market is segmented on the basis of delivery system, mode, application, and method.
The Global Gene Delivery Technologies Market by Delivery System
- Viral Gene Delivery Systems
- Non-viral Gene Delivery System
- Combined Hybrid Delivery Systems
The Global Gene Delivery Technologies Market by Mode
- AAV
- Lentivirus
- Retrovirus
The Global Gene Delivery Technologies Market by Application
- Gene Therapy
- Cell Therapy
- Vaccines
- Research
The Global Gene Delivery Technologies Market by Method
- Ex Vivo
- In Vivo
- Others
Company Profiles
The companies covered in the report include
- Thermo Fisher Scientific Inc.
- Oxford Biomedica
- SignaGen Laboratories
- Synbio Technologies
- SIRION Biotech
- Novartis AG
- Bio-Rad Laboratories, Inc
- OriGene Technologies, Inc.
- Promega Corporation
- Others
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the gene delivery technologies market.
2. Complete coverage of all the segments in the gene delivery technologies market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global gene delivery technologies market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Gene Delivery Technologies Market Highlights
2.2. Gene Delivery Technologies Market Projection
2.3. Gene Delivery Technologies Market Regional Highlights
Chapter 3. Global Gene Delivery Technologies Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Delivery System
3.4.2. IGR-Growth Matrix Analysis by Mode
3.4.3. IGR-Growth Matrix Analysis by Application
3.4.4. IGR-Growth Matrix Analysis by Method
3.4.5. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Gene Delivery Technologies Market
Chapter 4. Gene Delivery Technologies Market Macro Indicator Analysis
Chapter 5. Global Gene Delivery Technologies Market by Delivery System
5.1. Viral Gene Delivery Systems
5.2. Non-viral Gene Delivery System
5.3. Combined Hybrid Delivery Systems
Chapter 6. Global Gene Delivery Technologies Market by Mode
6.1. AAV
6.2. Lentivirus
6.3. Retrovirus
Chapter 7. Global Gene Delivery Technologies Market by Application
7.1. Gene Therapy
7.2. Cell Therapy
7.3. Vaccines
7.4. Research
Chapter 8. Global Gene Delivery Technologies Market by Method
8.1. Ex Vivo
8.2. In Vivo
8.3. Others
Chapter 9. Global Gene Delivery Technologies Market by Region 2023-2030
9.1. North America
9.1.1. North America Gene Delivery Technologies Market by Delivery System
9.1.2. North America Gene Delivery Technologies Market by Mode
9.1.3. North America Gene Delivery Technologies Market by Application
9.1.4. North America Gene Delivery Technologies Market by Method
9.1.5. North America Gene Delivery Technologies Market by Country
9.1.5.1. The U.S. Gene Delivery Technologies Market
9.1.5.1.1. The U.S. Gene Delivery Technologies Market by Delivery System
9.1.5.1.2. The U.S. Gene Delivery Technologies Market by Mode
9.1.5.1.3. The U.S. Gene Delivery Technologies Market by Application
9.1.5.1.4. The U.S. Gene Delivery Technologies Market by Method
9.1.5.2. Canada Gene Delivery Technologies Market
9.1.5.2.1. Canada Gene Delivery Technologies Market by Delivery System
9.1.5.2.2. Canada Gene Delivery Technologies Market by Mode
9.1.5.2.3. Canada Gene Delivery Technologies Market by Application
9.1.5.2.4. Canada Gene Delivery Technologies Market by Method
9.1.5.3. Mexico Gene Delivery Technologies Market
9.1.5.3.1. Mexico Gene Delivery Technologies Market by Delivery System
9.1.5.3.2. Mexico Gene Delivery Technologies Market by Mode
9.1.5.3.3. Mexico Gene Delivery Technologies Market by Application
9.1.5.3.4. Mexico Gene Delivery Technologies Market by Method
9.2. Europe
9.2.1. Europe Gene Delivery Technologies Market by Delivery System
9.2.2. Europe Gene Delivery Technologies Market by Mode
9.2.3. Europe Gene Delivery Technologies Market by Application
9.2.4. Europe Gene Delivery Technologies Market by Method
9.2.5. Europe Gene Delivery Technologies Market by Country
9.2.5.1. Germany Gene Delivery Technologies Market
9.2.5.1.1. Germany Gene Delivery Technologies Market by Delivery System
9.2.5.1.2. Germany Gene Delivery Technologies Market by Mode
9.2.5.1.3. Germany Gene Delivery Technologies Market by Application
9.2.5.1.4. Germany Gene Delivery Technologies Market by Method
9.2.5.2. United Kingdom Gene Delivery Technologies Market
9.2.5.2.1. United Kingdom Gene Delivery Technologies Market by Delivery System
9.2.5.2.2. United Kingdom Gene Delivery Technologies Market by Mode
9.2.5.2.3. United Kingdom Gene Delivery Technologies Market by Application
9.2.5.2.4. United Kingdom Gene Delivery Technologies Market by Method
9.2.5.3. France Gene Delivery Technologies Market
9.2.5.3.1. France Gene Delivery Technologies Market by Delivery System
9.2.5.3.2. France Gene Delivery Technologies Market by Mode
9.2.5.3.3. France Gene Delivery Technologies Market by Application
9.2.5.3.4. France Gene Delivery Technologies Market by Method
9.2.5.4. Italy Gene Delivery Technologies Market
9.2.5.4.1. Italy Gene Delivery Technologies Market by Delivery System
9.2.5.4.2. Italy Gene Delivery Technologies Market by Mode
9.2.5.4.3. Italy Gene Delivery Technologies Market by Application
9.2.5.4.4. Italy Gene Delivery Technologies Market by Method
9.2.5.5. Rest of Europe Gene Delivery Technologies Market
9.2.5.5.1. Rest of Europe Gene Delivery Technologies Market by Delivery System
9.2.5.5.2. Rest of Europe Gene Delivery Technologies Market by Mode
9.2.5.5.3. Rest of Europe Gene Delivery Technologies Market by Application
9.2.5.5.4. Rest of Europe Gene Delivery Technologies Market by Method
9.3. Asia Pacific
9.3.1. Asia Pacific Gene Delivery Technologies Market by Delivery System
9.3.2. Asia Pacific Gene Delivery Technologies Market by Mode
9.3.3. Asia Pacific Gene Delivery Technologies Market by Application
9.3.4. Asia Pacific Gene Delivery Technologies Market by Method
9.3.5. Asia Pacific Gene Delivery Technologies Market by Country
9.3.5.1. China Gene Delivery Technologies Market
9.3.5.1.1. China Gene Delivery Technologies Market by Delivery System
9.3.5.1.2. China Gene Delivery Technologies Market by Mode
9.3.5.1.3. China Gene Delivery Technologies Market by Application
9.3.5.1.4. China Gene Delivery Technologies Market by Method
9.3.5.2. Japan Gene Delivery Technologies Market
9.3.5.2.1. Japan Gene Delivery Technologies Market by Delivery System
9.3.5.2.2. Japan Gene Delivery Technologies Market by Mode
9.3.5.2.3. Japan Gene Delivery Technologies Market by Application
9.3.5.2.4. Japan Gene Delivery Technologies Market by Method
9.3.5.3. India Gene Delivery Technologies Market
9.3.5.3.1. India Gene Delivery Technologies Market by Delivery System
9.3.5.3.2. India Gene Delivery Technologies Market by Mode
9.3.5.3.3. India Gene Delivery Technologies Market by Application
9.3.5.3.4. India Gene Delivery Technologies Market by Method
9.3.5.4. South Korea Gene Delivery Technologies Market
9.3.5.4.1. South Korea Gene Delivery Technologies Market by Delivery System
9.3.5.4.2. South Korea Gene Delivery Technologies Market by Mode
9.3.5.4.3. South Korea Gene Delivery Technologies Market by Application
9.3.5.4.4. South Korea Gene Delivery Technologies Market by Method
9.3.5.5. Australia Gene Delivery Technologies Market
9.3.5.5.1. Australia Gene Delivery Technologies Market by Delivery System
9.3.5.5.2. Australia Gene Delivery Technologies Market by Mode
9.3.5.5.3. Australia Gene Delivery Technologies Market by Application
9.3.5.5.4. Australia Gene Delivery Technologies Market by Method
9.3.5.6. Rest of Asia-Pacific Gene Delivery Technologies Market
9.3.5.6.1. Rest of Asia-Pacific Gene Delivery Technologies Market by Delivery System
9.3.5.6.2. Rest of Asia-Pacific Gene Delivery Technologies Market by Mode
9.3.5.6.3. Rest of Asia-Pacific Gene Delivery Technologies Market by Application
9.3.5.6.4. Rest of Asia-Pacific Gene Delivery Technologies Market by Method
9.4. RoW
9.4.1. RoW Gene Delivery Technologies Market by Delivery System
9.4.2. RoW Gene Delivery Technologies Market by Mode
9.4.3. RoW Gene Delivery Technologies Market by Application
9.4.4. RoW Gene Delivery Technologies Market by Method
9.4.5. RoW Gene Delivery Technologies Market by Sub-region
9.4.5.1. Latin America Gene Delivery Technologies Market
9.4.5.1.1. Latin America Gene Delivery Technologies Market by Delivery System
9.4.5.1.2. Latin America Gene Delivery Technologies Market by Mode
9.4.5.1.3. Latin America Gene Delivery Technologies Market by Application
9.4.5.1.4. Latin America Gene Delivery Technologies Market by Method
9.4.5.2. Middle East Gene Delivery Technologies Market
9.4.5.2.1. Middle East Gene Delivery Technologies Market by Delivery System
9.4.5.2.2. Middle East Gene Delivery Technologies Market by Mode
9.4.5.2.3. Middle East Gene Delivery Technologies Market by Application
9.4.5.2.4. Middle East Gene Delivery Technologies Market by Method
9.4.5.3. Africa Gene Delivery Technologies Market
9.4.5.3.1. Africa Gene Delivery Technologies Market by Delivery System
9.4.5.3.2. Africa Gene Delivery Technologies Market by Mode
9.4.5.3.3. Africa Gene Delivery Technologies Market by Application
9.4.5.3.4. Africa Gene Delivery Technologies Market by Method
Chapter 10. Company Profiles and Competitive Landscape
10.1. Competitive Landscape in the Global Gene Delivery Technologies Market
10.2. Companies Profiles
10.2.1. Thermo Fisher Scientific Inc.
10.2.2. Oxford Biomedica
10.2.3. SignaGen Laboratories
10.2.4. Synbio Technologies
10.2.5. SIRION Biotech
10.2.6. Novartis AG
10.2.7. Bio-Rad Laboratories, Inc
10.2.8. OriGene Technologies, Inc.
10.2.9. Promega Corporation
10.2.10. Others
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security